权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Homocysteine, Adiponectin, and Alcoholic Liver Disease

同型半胱氨酸、脂联素和酒精性肝病

基本信息

批准号：
8516404
负责人：
ZHENYUAN SONG
金额：
$ 26.4万
依托单位：
UNIVERSITY OF ILLINOIS AT CHICAGO
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-08-05 至 2015-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8516404
关键词：
Adenosylhomocysteinase Adipocytes Adipose tissue Alcohol consumption Alcoholic Fatty Liver Alcoholic Liver Diseases Alcohols Animals Attention Benign Betaine Biochemical Cell Culture Techniques Chronic Cirrhosis Clinical Research Data Development Dietary Intervention Disease Disease Progression Down-Regulation Energy Metabolism Ethanol Ethanol Metabolism Experimental Models Fatty Liver Fatty acid glycerol esters Fibrosis Gene Expression Health Hepatic Hepatocyte Homocysteine Homocystine Hyperhomocysteinemia Individual Inflammation Infusion procedures Knock-out Lead Liver Liver diseases Maintenance Mediator of activation protein Metabolism Methionine Methionine Metabolism Pathway Methyltransferase Modeling Mus Necrosis Pathogenesis Pathway interactions Physiological Plasma Play Principal Investigator Process Production Property Proteins Reaction Regulation Reporting Rodent Role S-Adenosylmethionine Staging Steatohepatitis Subarachnoid Hemorrhage Technology Therapeutic Effect United States Work adiponectin alcohol exposure base carbohydrate metabolism chronic alcohol ingestion clinically relevant design feeding inhibitor/antagonist lipid metabolism liver inflammation liver injury novel therapeutic intervention prevent programs protective effect research study restoration saturated fat transmethylation

项目摘要

DESCRIPTION (provided by applicant): Chronic alcohol exposure causes the development and maintenance of fatty liver by interfering hepatic fat disposal. Adiponectin, an adipokine predominantly secreted by adipose tissue, plays a central role in the regulation of energy metabolism, lipid and carbohydrate metabolism. Accumulated evidence suggests that down- regulation of adiponectin production has patho-physiological importance in the process of alcoholic fatty liver disease; however, the underlying mechanisms are still elusive. Abnormal hepatic methionine/homocysteine metabolism and hyperhomocysteinemia induced by prolonged alcohol exposure has been reported both in clinical and experimental studies, however, the occurrence of this abnormality in adipose tissue, as well as its potential implication in the regulation of adipose tissue function, specifically adiponectin expression and secretion, has received very few attention. It is our hypothesis that chronic alcohol exposure induces abnormal methionine/homocysteine metabolism not only in the liver, but also in the adipose tissue. Furthermore, we hypothesize that increased accumulation of homocysteine in the adipocytes, either via alcohol-induced endogenous alteration in methionine/homocysteine metabolism or a cross-talk from the liver; contribute to the suppression of adiponectin gene expression and secretion in alcoholic liver disease (ALD). In this proposal, we will utilize both animal and cell culture models to evaluate excessive accumulation of homocysteine in the adipocytes by chronic alcohol feeding as a mechanism for decreased adiponectin gene expression, protein production and secretion. The specific objectives of this project are as follows: 1. Further document the effects of chronic alcohol consumption on methionine/homocysteine metabolism in adipose tissues and explore potential mechanisms involved in this process; 2. Determine the effects of increased homocysteine accumulation in adipocytes on adiponectin production and its causal role in the inhibitory effects of chronic alcohol exposure on adiponectin production in ALD; 3. Elucidate mechanisms whereby homocysteine modulates adiponectin production. The beneficial effects of nutritional intervention, specifically these being able to rectify abnormal methionine/homocysteine metabolism such as betaine and S-adenosylmethionine, have been well-accepted; thus, our approach is designed to not only more completely understand the mechanisms of ALD, but also to develop new therapeutic interventions. PHS 398/2590 (Rev. 09/04, Reissued 4/2006) Page Continuation Format Page PUBLIC HEALTH RELEVANCE: Alcoholic liver disease (ALD) remains an important health problem in the United States. Adiponectin is a soluble mediator predominantly secreted by adipose tissue and in possession of properties of anti-steatosis, anti-inflammation, and anti-fibrosis. Chronic alcohol exposure results in suppressed adiponectin production, which plays an important role in the pathogenesis of ALD. Based on our preliminary findings that chronic alcohol feeding caused elevation of homocysteine levels in the adipose tissue and homocysteine decreased adiponectin production by primary adipocytes, we propose here that altered methionine/homocysteine metabolism both in the liver and in the adipose tissue may play a mechanistic role in the suppression of adiponectin production in ALD. We will use the state-of-the-art technologies to investigate this clinically relevant process.

描述（由申请方提供）：长期酒精暴露通过干扰肝脏脂肪处理导致脂肪肝的发展和维持。脂联素是一种主要由脂肪组织分泌的脂肪细胞因子，在能量代谢、脂类和糖类代谢中起着重要的调节作用。越来越多的证据表明脂联素产生的下调在酒精性脂肪肝的发病过程中具有重要的病理生理学意义，但其潜在机制仍不清楚。长期酒精暴露引起的肝脏甲硫氨酸/同型半胱氨酸代谢异常和高同型半胱氨酸血症在临床和实验研究中都有报道，然而，脂肪组织中这种异常的发生，以及其在脂肪组织功能调节中的潜在意义，特别是脂联素的表达和分泌，很少受到关注。我们的假设是，慢性酒精暴露不仅在肝脏中，而且在脂肪组织中诱导异常的蛋氨酸/同型半胱氨酸代谢。此外，我们推测，增加积累的同型半胱氨酸在脂肪细胞中，无论是通过酒精诱导的内源性改变蛋氨酸/同型半胱氨酸代谢或从肝脏的串扰;有助于抑制脂联素基因的表达和分泌酒精性肝病（ALD）。在这个建议中，我们将利用动物和细胞培养模型，以评估过度积累的同型半胱氨酸在脂肪细胞中的慢性酒精喂养作为一种机制，降低脂联素基因表达，蛋白质的生产和分泌。本项目的具体目标如下：1.进一步研究长期饮酒对脂肪组织中蛋氨酸/同型半胱氨酸代谢的影响，并探讨其可能的作用机制。确定脂肪细胞中同型半胱氨酸积累增加对脂联素产生的影响及其在慢性酒精暴露对ALD中脂联素产生的抑制作用中的因果关系; 3.阐明同型半胱氨酸调节脂联素产生的机制。营养干预的有益效果，特别是能够纠正异常蛋氨酸/同型半胱氨酸代谢（如甜菜碱和S-腺苷甲硫氨酸）的有益效果已被广泛接受;因此，我们的方法不仅旨在更全面地了解ALD的机制，而且还旨在开发新的治疗干预措施。PHS 398/2590（Rev. 09/04，Reissued 4/2006）Page Continuation Format Page公共卫生相关性：酒精性肝病（ALD）在美国仍然是一个重要的健康问题。脂联素是一种主要由脂肪组织分泌的可溶性介质，具有抗脂肪变性、抗炎和抗纤维化的作用。慢性酒精暴露导致脂联素的产生受到抑制，在ALD的发病机制中起重要作用。基于我们的初步研究结果，即慢性酒精喂养引起脂肪组织中同型半胱氨酸水平升高，同型半胱氨酸降低了原代脂肪细胞的脂联素产生，我们在这里提出，改变蛋氨酸/同型半胱氨酸代谢在肝脏和脂肪组织中可能发挥机制作用，在抑制脂联素的生产ALD。我们将使用最先进的技术来研究这一临床相关过程。